Skip to main content
. 2017 Jan 30;19:12. doi: 10.1186/s12968-017-0325-y

Fig. 3.

Fig. 3

Infarct and myocardium at risk (MaR) in vivo and ex vivo. The upper row shows infarct by late gadolinium enhancement (LGE) and MaR by CE-SSFP in vivo and the lower row shows infarct by high-resolution T1-weighted imaging and MaR by CE-SSFP ex vivo. Note the significantly larger MaR compared to infarction both in vivo and ex vivo